Market Research Blog – Page 15523 – New Product Development

Foley Catheter Market Insights with Upcoming Trends Segmentation, Opportunities and Forecast to 2030

The prevalence of urological diseases – such as urinary retention, benign prostate hyperplasia (BPH), bladder obstruction, urinary incontinence, and prostate cancer – has witnessed a significant uptick in the recent past. According to the statistics of the Centers for Disease Control and Prevention (CDC), nearly 15-25% of hospitalized patients receive a urinary catheter annually. As the number of hospital admissions continues to rise year-on-year, there is a persistent need for foley catheters in hospitals, which are projected to remain a crucial end-use segment.

Likewise, the growing burden of urinary retention, a chronic condition in which individuals cannot voluntarily urinate, is propelling demand for foley catheters to facilitate easy drainage of urine. As per the estimates of the American Academy of Family Physicians (AAFP), approximately 4.5 to 6.8 per 1,000 men in the US suffer from urinary retention. As the incidence of disorders continues to grow across the world, the demand for foley catheters is poised to remain high for the years to come.

Along similar lines, the high prevalence of urinary incontinence, a condition that causes the urine to leak involuntarily, is projected to bestow remunerative opportunities to players in the foley catheters market. The severity of urinary incontinence rises with age, with men above 70 being the most affected. The expanding base of the geriatric population will continue to necessitate the usage of foley catheters.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-7769

Having analyzed and scrutinized all the aforementioned facets in its new market study, Future Market Insights (FMI) projects that the global foley catheters market will grow in value at a CAGR of nearly 5% between 2020 and 2030. Some of the key takeaways from the report include:

The global foley catheters market is expected to surge past valuation of US$ 2.2 Bn by the end of 2030.
By product type, 2-way foley catheters are poised to remain the most sought-out variants, owing to their wide availability and simple installation, and will hold more than half of the overall market value.
Among materials, latex-based foley catheters are expected to gain an edge over their counterpart, silicon-based foley catheters, backed by their ability to reduce urethral irritation.
Based on indication, urinary incontinence is expected to remain the largest segment, on the back of high incidence among geriatric population.
North America will remain at the forefront of the regional landscape ascribed to high expenditure on medical aids coupled with new product approvals.
Asia Pacific and Europe will continue to bestow remunerative opportunities to market players.

COVID-19 Impact on Foley Catheters Market

COVID-19 is expected to create slight fluctuations in the growth trajectory of the foley catheters market. There has been a notable shift in priorities of healthcare institutions, with treatment for COVID-19 patients being the utmost priority across the world. Hospitals in severely affected nations such as the US and India have deprioritized non-essential hospitalizations, leading to a downfall in the demand for foley catheters. With urology not being the most concerning healthcare issue currently, the sales of numerous urology care devices, including foley catheters are likely to witness a decline across hospitals. However, the demand for foley catheters in long-term care facilities is poised to remain unhinged through the pandemic, and will continue to drive the sales of these devices.

Who is Winning?

Major players in the market are focusing on developing advanced catheters that reduce the likelihood of the patient developing catheter-associated infections. To achieve the same, they are using novel materials and coatings, and are seeking approvals to commercialize their devices.

FMI’s report includes profiles of some of the most prominent names in the market including Teleflex Incorporated, Cardinal Health, C.R Bard, B. Braun Melsungen AG, Coloplast A/S, Medtronic plc, Flume, ConvaTec Group, VOTG Medical, Sterimed Group, Ribbel International Limited, Angiplast Private Limited, Mais India Medical Devices Private Limited, and JK Medirise.

For critical insights, request for PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-7769

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Biological & Chemical Indicators Market Growth Trends, Key Players, Competitive Strategies and Forecasts to 2030

According to Future Market Insights (FMI) the worldwide yearly tracker, vendor revenue in global biological & chemical indicators market will grow 9.1% year over year to 396.8 Mn in 2020. Global shipments will rise 9.7% year over year to 830.7 Mn units in 2020.

Irrespective of the COVID-19 pandemic, demand for biological and chemical indicators has been surging tremendously as sterilization has always been at forefront of duties of healthcare facilities.

However, the role will be put to test in near future as epidemiological numbers continue to rise amidst the public health crisis. As such, FMI foresees healthy growth trail for global biological and chemical indicators market over forecast period 2020-2030.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-12544

Biological & Chemical Indicators Market Size Study

Thermal sterilization will remain preferred sterilization type through 2030
Biological indicators (BI) continue to stay high in demand, enzyme indicators to gain traction
Players to stay glued to self-contained BIs, as they lead to shorter required incubation times
Biopharma industry to remain primary end user of biological and chemical indicators over following decade
Stakeholders to reap substantial revenue from North America and Europe, given presence of advanced healthcare infrastructure

COVID-19 Impact on Biological & Chemical Indicators Market

The COVID-19 pandemic will trigger the demand for biological and chemical indicators for short-term to validate sterilization process in hospitals, ambulatory surgical centers (ASC), and clinics.

The pandemic has put pressure on frontline healthcare workers to follow strict cleaning and disinfection protocols as they are specifically at risk of contracting and spreading the infection. This has triggered the need for sterilization measures enacted during surgical procedures due to concerns of COVID-19 transmission among hospitalized patients.

The World Health Organization (WHO) has advised personal protective equipment (PPE) industry and governments to ramp up their manufacturing by 40% to cater to surging worldwide demand. This high pool of medical equipment with need for proper sterilization will bode well for biological & chemical indicators market in immediate future.

Biological & Chemical Indicators Market – Competitive Intelligence

The global biological & chemical indicators market is highly consolidated with top 5 players – 3M Company, Steris Plc., and Thermo Fisher – collectively accounting for around 4/5 of overall market revenue. In order to sustain competition due to increasing number of new and small companies, leading players are focusing on mergers and acquisitions (M&A).

For critical insights, request for PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-12544

Why Future Market Insights?

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Contact Us:

Surgical Mask Market Perspective, Comprehensive Analysis, Growth and Forecast 2020-2030

Short-term demand for surgical masks remains unprecedented, however, growing awareness regarding their effectiveness will lead to steady sales in the long-term, according to a latest study by Future Market Insights. According to the study, even after the COVID-19 pandemic is brought under control, a sizeable percentage of people are likely to continue wearing masks in crowded places, and cities where pollution levels are high.

Key Report Takeaways

The global surgical masks market is forecasted to surge past valuation of US$ 4.2 Bn by 2030
Basic surgical masks and fluid/splash resistant surgical masks are expected to collectively account for 80% of market value, each holding a share of near-equal proportions.
The adoption of basic surgical masks is concentrated among general consumers while fluid/splash resistant surgical masks find a majority of takers among medical professionals.
By end-use, hospitals are foreseen to channel the majority of revenue, capturing more than 70% of market value.
Ambulatory surgical centers are anticipated to remain the second-most lucrative market, accounting for more than 1/5th of global market value.
Europe is poised to capture the lion’s share in market value, accounting for a share little below 2/5th of market value.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-11197

Through the years, surgical masks have remained one of the most prominent protective equipment among healthcare professionals while performing medical procedures.

Surgical masks offer protection against exposure to harmful bacteria and other organisms present in the blood and other bodily fluids that the medical professionals are likely to come in contact with during surgical procedures.

As the number of surgeries continues to increase in direct proportion with the expanding base of the geriatric population, the demand for protective surgical equipment, including surgical masks, is expected to prevail high for the years to come.

As per the statistics of The Lancet, the number of surgeries conducted across the world surged passed 313 Mn in recent years and continues to rise year-on-year, offering substantial revenue opportunities to market players.

Likewise, high levels of air pollution in East Asian nations such as China, South Korea, and Japan have made wearing masks a common practice among the population of these regions.

Besides, the sales of masks in the aforementioned regions have historically witnessed an upsurge during the flu seasons. On these lines, the outbreak of COVID-19 is creating an unprecedented demand for surgical masks, as they become an integral part of routine during the pandemic.

COVID-19 Impact on Surgical Masks Market

The outbreak of COVID-19 has proven fruitful to the manufacturers of surgical masks, as demand for surgical masks has never been higher. As the number of infections continues to spike in large nations such as the US, India, Brazil, and Russia, with no vaccine approval in sight, people are resorting to all kinds of protective measures in their routine.

On this premise, surgical masks have emerged as the most accessible and efficient safety measure, and have become an integral part of their lives. Surgical masks are currently among the most sought out essentials and are poised to remain through the pandemic, thus catalyzing the overall market growth.

Who is Winning?

Key players operating in the market are capitalizing on the demand created during the pandemic and are upscaling their production capacities to gain a competitive edge. Moreover, market players are focusing on procuring approvals for new products to distribute on a wide-scale.

FMI’s report includes profiles of some of the most prominent names in the market including 3M, Honeywell International Inc., and Medline Industries, Inc., Halyard Health (Owens & Minor, Inc.), Kimberly-Clark Worldwide, Inc., Medline Industries, Inc., Moldex-Metric Inc., Kowa Company Ltd., Premium HealthCare Disposables Private Limited, Kindwell Medical BioClean (ANSELL LTD.), Dynarex Corp., and Valmy among others.

For critical insights, request for PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-11197

Why Future Market Insights?

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Contact Us:

PD-L1 Biomarker Testing Market Trends, Strong Application Scope, Key Players, Growth Overview and Forecast by 2030

As the prevalence of lung cancer, melanoma, and renal cell carcinoma continues to soar worldwide, the adoption of PD-L1 biomarker testing is expected to grow at a healthy pace in the years to come, says Future Market Insights (FMI) in its new market study. Moreover, the report forecasts that the global PD-L1 biomarker testing market will grow in value at a stellar CAGR of 13.1% between 2020 and 2030.

The report opines that the outbreak of COVID-19 is likely to create short-term fluctuations on the supply side due to pandemic-related issues such as workforce shortages and disruptions of delivery networks. Similarly, a steep decline in the number of tests has been observed during the pandemic, and this is expected to further decelerate the demand for PD-L1 biomarker testing.

The report primarily attributes the growth of the market to the increasing incidence of cancers, especially lung and skin, coupled with the development of advanced diagnostic kits and assays.

Likewise, rising awareness regarding the availability of testing methodology such as immunohistochemistry-based assays and Enzyme-linked Immunoassay (ELISA) based detection will continue to impel the adoption of PD-L1 biomarkers in the forthcoming years.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-5897

Key Takeaways

The global PD-L1 biomarkers testing market is expected to surge past valuation of US$ 2.05 Bn by the end of the forecast period.
PD-L1 SP142 assay kits will remain the most popular products among end-users, capturing nearly half of the market value, owing to high efficiency in detecting cancer tumors.
Non-small cell lung cancer and melanoma are cumulatively expected to hold more than 50% of the total market value on the back of the soaring prevalence of these diseases.
By end-use, PD-lL1 biomarker testing finds the majority of applications in hospitals, which is expected to account for over 60% of market value.
North America will spearhead the regional landscape through the forecast period, accounting for more than 50% of the global market value.
Europe is poised to remain the second most lucrative region, holding nearly 1/3rd of market value.

COVID-19 Impact on PD-L1 Biomarker Testing Market

The COVID-19 pandemic has created disruptions across the healthcare technology landscape and has resulted in a shifting preference among manufacturers towards essential technologies and treatments. Furthermore, although PD-L1 biomarker testing is used to test severe diseases such as cancer, a reduced number of screenings is adversely impacting the demand for testing.

For instance, according to trends observed by Cancer Research Network, screening rates of melanoma plummeted by approximately 50% in the UK in the past few months. Likewise, in the US, the number of tests conducted to detect non-small cell lung cancer fell by 30% in March as compared to February. As patients reschedule or skip regular screenings, this is creating a downtrend in demand for PL-D1 biomarker testing.

However, considering the severity of these diseases, the need for testing will swiftly arise in the future, ensuring that the market’s growth trajectory remains intact.

Who is Winning?

Key players operating in the market are focusing on enhancing existing product designs and developing novel products with increased accuracy. Moreover, traditional growth strategies such as acquisitions and mergers have been identified as strategies adopted by players to strengthen their foothold in the competitive landscape.

FMI’s report includes profiles of some of the most prominent names in the market including F. Hoffmann-La Roche Ltd, Agilent Technologies, Inc., NeoGenomics Laboratories, Inc, HalioDx and Abcam plc. among others.

For critical insights, request for PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-5897

Why Future Market Insights?

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Contact Us:

Stethoscope Market Covid-19 Impact Analysis, Size, Share, Key Trends, Demand and Forecast till 2030

Stethoscope being an integral part of the modern medical diagnosis sector, has been gaining significant traction. According to a recent study by Future Market Insights, the stethoscope market is forecast to expand at above 5% CAGR between 2020 and 2030.

Stethoscopes are often considered a physician’s third hand and the current digital advancements have ensured better performance.

The key market players such as American Diagnostic Corporation, 3M Company, Eco Devices Inc. and others are investing heavily to offer digitization of various medical tools. They are focusing on technological advancements also gain competitive advantage in the global market. The leading companies have started developing electronic stethoscopes in order to detect critical cardiovascular conditions much earlier than the normal stethoscopes can.

The FMI report offers in-depth research and analysis of the global stethoscope market, its potential and growth scopes during the forecast period (2020-2030).

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-12675

Some of the key takeaways from the report are as given below-

The global stethoscope market is set to grow by 5.2% CAGR during the forecast period (2020-2030).

Cardiovascular (CVS) disease being the main area of focus for the application of stethoscope in the medical sector, is to remain in the top factors for the increase in market demand
By product acoustic stethoscope will keep leading the global market throughout the forecast period (2020-2030)
Physician office, home care settings, hospitals and others to remain the top end-users catering to the market growth throughout the forecast period. Of these, demand from hospitals is set to be higher
Region-wise North America and Latin America to lead the global market. Europe, South & East Asia, Oceania and MEA to sustain as other region-wise key players.

Rising Focus on Health and Wellbeing Boosting Growth

As people are getting more conscious about their health and well-being, the digitized sectors like stethoscope market is anticipated to expand further during the forecast period, reaching US$ ~ 914 Mn by the end of the year 2030. The recent COVID-19 pandemic has even accelerated the growth of medical diagnosis which is resulting in the steady market growth over the years in future.

Currently the global stethoscope market holds unlimited opportunities for the global market players and so, the dominant market holders have already started adopting various digitized tools and procedure to remain in the top places. For instance, the digital Eko CORE has brought their advanced algorithms which can automatically screen patients and is capable of providing up to 40x amplification of acoustic sound along with advanced noise elimination technology, as well as the modern flexible feature of switching between digital and acoustic modes.

COVID-19 Impact Analysis

Due the outbreak of novel coronavirus during the recent time, the demand of modern digitized stethoscopes has increased across the countries. The pandemic has created more awareness among the people as well as there is surge in the need of getting diagnosed earlier than the other times.

These altogether have increased the global stethoscope market demand among the top end-users, starting from physicians to hospitals or home care providers. As the increased concern regarding health, especially heart and lungs related issues tends to sustain, the COVID-19 impact on the global stethoscope market will be long-lasting, opening endless opportunities to the market players during the forecast period.

Who is winning?

The global stethoscope market being emerged as a highly potential domain for the market dominating companies, the key market holders are evolving by adoption of various modern technologies. The leading Companies like, Think Labs Medical LLC, Rudolf Riester GmbH, Meditech Equipment Co., Ltd. and others have started their research and release of various brand-new products to expand further throughout the forecast period (2020-2030).

For critical insights, request for PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-12675

Why Future Market Insights?

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Contact Us:

Ophthalmic Tonometers Market 2020: Global Industry Analysis, Size, Share, Growth, Trends And Forecast To 2030

Driven by recent technological advancements and rising cases of diabetes the ophthalmic tonometers market is forecast to expand considerably. According to Future Market Insights (FMI), the global ophthalmic tonometers market size is expected to reach US$ 445.5 Mn by the end of 2030.

As per the National Diabetes Report 2020 by CDC, 10.5 % of the U.S. population are diabetic. As a result a large portion of the population is prone to glaucoma. Ophthalmic tonometers are widely used by eye-specialists for eye test to check for the risk of glaucoma and hence the market growth is increasing in the present scenario.

Though the recent COVID-19 pandemic is affecting the current year market revenue, the global ophthalmic tonometers market is expected to grow further over the forecast period. The rising focus towards health and willingness to spend on advanced healthcare will enable growth in the market.

The FMI report offers an in-depth and unbiased analysis of the global ophthalmic tonometers market during the forecast period.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-12687

Some of the key takeaways from the report are given below-

The global ophthalmic tonometers market value is anticipated to grow by 4.8% CAGR during the forecast period from the year 2020 to 2030
Due to the rising cases of diabetes around the world, people are getting more vulnerable to glaucoma resulting in increased market demand
The advent of substitutes to measure intraocular pressure is expected to come in the way of market growth in the coming years
The increase in disposable prism development to minimize the infection spread while administering glaucoma patients will cater to the market demand in coming years
The increased awareness among people for earlier diagnosis and routine monitoring of intraocular pressure (IOP) to prevent permanent vision loss is expected to catalyze the market growth

Rising Demand for Advanced Technologies across Healthcare Facilities

As the key end-user industries such as hospitals, ophthalmic diagnostic centers and others are getting equipped with modern facilities, growth witnessed by the market is expected to continue throughout the forecast period. Also, the advent of disposable prism to prevent the diagnosis-related infection, is catering to the market growth.

Being an integral part of ophthalmic treatment, tonometers have evolved significantly over the years starting from a desktop held device to a smart handheld one. In order to measure the intraocular pressure for precise diagnosis for eye treatment, ophthalmic tonometers are utterly important and as a result the market demand is getting sky-high gradually.

COVID-19 Impact Analysis

Due to the COVID-19 pandemic the market demand has been witnessing sluggish growth as focus in general has shifted towards the emergency treatment due to the virus outbreak.

Furthermore, the shut downs of manufacturing units for long time, unavailability of labors, scarcity of raw materials and other factors have declined the market growth.

According to FMI, these restraining factors due to COVID-19 is expected to slow down the growth rate till the first quarter of 2021.

Despite of the negative effects of COVID-19, the global ophthalmic tonometers market is anticipated to exhibit steady growth during the forecast period.

Who is winning?

Impressive growth exhibited by the ophthalmic tonometers market will creative lucrative prospects for companies operating therein. To capitalize on it key market players such as Nidek, Jorgensen Laboratories, Topcon, Photon Surgical Systems Ltd., and others are launching advanced products along with adopting long-term strategic plans.

For instance, key market player Topcon has released their new computerized range of tonometers CT-1/CT-1P with the exclusive features such as flexible and space-saving layout, reliable measurements, R/L friendly automated measurement, and others.

For critical insights, request for PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-12687

Why Future Market Insights?

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Contact Us:

Microneedle Drug Delivery Systems Market Insights with Upcoming Trends Segmentation, Opportunities and Forecast to 2030

Emerging applications of microneedle drug delivery systems are expected to fuel their demand over the next decade. According to a recent report published by Future Market Insights (FMI), the global microneedle drug delivery systems market will grow at a CAGR of 6.6% between 2020 and 2030. The market is witnessing surging demand in the field of pharmacy and cosmetics.

The rising incidence of diseases such as cancer, diabetes, migraine, and others and the need to accurately administer medications are driving the market. Additionally, the demand for minimally invasive and painless treatment methods is expected to bode well for the market.

The report uncovers hidden growth opportunities. It also highlights potential threats to the market players. Some of the key takeaways from the report are highlighted below.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-2750

Key Takeaways from the Report

Solid microneedles are expected to lead the market during forecast period of 2020-2030 among product type
Hospitals are the leading end users of microneedle drug delivery systems, with specialty clinics gaining popularity.
Specialty clinics are expected to grow at an accelerated rate as one of the key end users of microneedle drug delivery systems
North America is the largest market for microneedle drug delivery systems. Along with Europe, it is expected to cover more than 70% of the market by end of 2030.
East Asia is expected to be the fastest growing regional market during the next decade.

Covid 19 Restricting Pace of Growth

The onset of pandemic has disturbed the entire business ecosystem. With productions coming to a halt and supply chains disrupted due to lack of transport, manufacturers of microneedle drug delivery systems are impacted in a big way.

Also, because of several restrictions by governments like social distancing, doctors and practitioners are choosing to avoid any surgical treatments which are not absolutely and immediately necessary.

Furthermore, cosmetic field which is another major user of microneedle drug delivery systems is also impacted as almost all treatments under their umbrella are considered to be not urgent.

Who is winning?

The key market players in microneedle drug delivery systems market include the 3M Company, Becton, Dickinson and Company, Zosano Pharma Corporation, Raphas co. ltd., Nanopass Tech, Corium International, Inc., Valeritas, Inc., Nitto Denko Corporation, Microdermics, Inc., TheraJect Inc., Vaxxas Pty Ltd., Endoderma Ltd., QuadMedicine, SNvia Co., Ltd., Small Lab and AdminMed Nano BioSciences LLC

Consolidating their positions through mergers, acquisitions and new product launches, global microneedle drug delivery systems market players rely heavily on new product innovation and differentiation for gaining an edge over their competitors.

For critical insights, request for PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-2750

Why Future Market Insights?

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Contact Us:

Poultry Diagnostics Market Growth Trends, Key Players, Competitive Strategies and Forecasts to 2030

Future Market Insights in its new report has projected positive growth prospects for the poultry diagnostics market for the assessment period between 2020 and 2030. High consumption of chicken on a global scale and increasingly strict food safety standards in developed countries will held aid growth.

Widespread outbreaks of infectious diseases such as avian influenza is a key factor driving the demand for diagnostic infrastructure in the poultry industry. Also, awareness campaigns by public and private bodies about avian diseases among poultry farmers is positively influencing the industry.

Furthermore, concerns over food security and investments by governments and international bodies towards the intensive farming sector will drive cultivation of poultry. This will also support the demand for poultry diagnostics in the long-term.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-12773

Key Takeaways

ELISA tests are expected to continue holding major market share through 2030, owing to superior accuracy and cost efficiency.
Diagnostics for avian influenza has been estimated to reflect higher market share on the back of widespread incidences in developing countries.
Newer ailments such as mortality syndrome are expected to generate lucrative opportunities in terms of product development and interest from the veterinary sector.
Virology services are expected to be a major contributor to the market owing to higher risk from viral infections for human consumers.
South Asia & Pacific, will reflect fast growth, with poor hygiene standards in developing nations. North America will continue to hold larger market share, owing to superior infrastructure.

Insights on the Coronavirus Impact

As the covid-19 outbreak continues to wreak havoc on the global economy, the poultry diagnostics market is expected to also be adversely impacted during the crisis period. While chickens and other poultry birds are not at risk to the virus, the pandemic is likely to hurt consumption, logistics, and sales of birds. This can be largely attributed to strict regulations on the food service businesses.

These factors are expected to reduce chicken stocks in the poultry industry for the short term, which in turn will reduce the demand for diagnostic tools and infrastructure in the industry. The market is likely to recover strongly towards 2021, as demand for poultry products picks up. Strict food safety laws and concerns over other strains of coronavirus will aid market developments.

Market Competitiveness

Market leaders in the poultry diagnostic industry include but are not limited to Agrobiotek Internacional, Bioneer Corporation, Affinitech Ltd., Zoetis Inc., Biochek, Thermo Fisher Scientific, Bioingentech Biotechnologies Inc., Qiagen N.V., Bionote Inc., Megacor Diagnostik GmbH, and Idexx Laboratories Inc.

Market participants are increasingly focused on the product research with the aim of developing and launching improved testing tools for faster and accurate results. In addition, strategic industry collaborations and acquisitions are being used to build a foundation in a moderately competitive landscape.

For critical insights, request for PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-12773

Why Future Market Insights?

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Contact Us:

In Vitro Fertilization Banking Services Market Trend 2020, Growth, Leading Companies with Impact of Covid-19, Business Scenario, Emerging Dynamics, Industry Share and Revenue Forecast by 2030

The in vitro fertilization (IVF) banking services market is gaining traction owing to the growing rate of infertility around the world. A recent study by the World Health Organization (WHO) states that infertility affects around 15% couples annually around the world.

Due to the growing cases of cancer the adoption of in vitro fertilization (IVF) is rising substantially among cancer patients, which in turn is fuelling the demand for in vitro fertilization banking services.

The increase in investment in order to obtain safe and secure sperm/egg storage facility coupled with the rising focus on cost-effective in vitro fertilization banking services is bolstering the growth of the market.

The healthcare industry is expanding fast and incorporating cutting edge technologies and equipment in their services. This in turn is aiding the expansion of the in vitro fertilization banking services market. It also is expected to gain from favourable government policies across various nations.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-12789

According to Future Market Insights (FMI), the global in vitro fertilization banking services market is anticipated to grow at over 11% CAGR during the forecast period from the year 2020 to 2030.

Despite facing a few difficulties due to COVID-19 pandemic, the market is projected to grow steadily in the coming years.

FMI offers an exhaustive overview of the in vitro fertilization banking services market, along with information on its potential, growth drivers, and restraints.

Some of the key takeaways from the report are highlighted below

The demand for egg banking services is expected to surge considerably in the coming years
Europe will lead in the in vitro fertilization banking services market throughout the forecast period
Latin America will emerge lucrative in the in vitro fertilization banking services market in the coming years
The rising demand for andrology services will augment growth prospects
Fresh donor egg cycle services will remain highly sought-after among various egg banking services available

COVID-19 Impact Analysis

In vitro fertilization is a costly and time consuming process hence the financial crisis caused due to the COVID-19 pandemic has severely affected the in vitro fertilization banking services market.

As the focus has shifted towards emergency services in healthcare sector, the demand for in vitro fertilization has been decreased substantially affecting the growth of in vitro fertilization banking services market.

Though the market has been affected due to the pandemic, it is anticipated to get back to its feet by the end of the year 2021 creating ample of opportunities for the key market players.

Who is Winning

The global in vitro fertilization banking services market is forecast to grow exponentially in the coming years. In order to capitalize on prevalent opportunities, key market players are focusing on providing a wide range of services.

MyEggBank has signed an agreement with Cryoport, Inc., the world’s leading temperature-controlled logistics company dedicated to the life sciences industry in February, 2020 in order to utilize Cryoport’s temperature-controlled supply chain solutions to deliver a superior patient experience.

For critical insights, request for PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-12789

Why Future Market Insights?

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Contact Us:

Mammalian Transient Protein Expression Market Analysis (COVID-19 Analysis) – Industry Insights, Drivers, Top Trends, Global Analysis, Forecast and Opportunities to 2030

Global mammalian transient protein market revenues are projected to surpass US$ 540 million in 2020, according to a new study by Future Market Insights (FMI). The report also states that, innovations in automation and recombinant proteins will support market developments, however, prohibitive costs and complexity to maintain media purity remain challenges.

Key Takeaways on Mammalian Transient Protein Expression Market

The size of the mammalian transient protein expression market is estimated to reach approximately US$ 540 Mn by the end of 2020, with antibody and therapeutic protein production applications being the primary factors driving growth in the industry.
Biopharmaceutical companies will remain prominent end-users of mammalian transient protein expression, while CROs are also likely to reflect steady growth on the back of biologics and drug development endeavours.
Chinese hamster ovary cells in terms of cell lines reflect relatively higher demand, owing to applications in academic and research uses, accounting for ~70% of market share by 2030.
North America followed by Europe are leading markets for mammalian transient protein expression, access to cutting edge healthcare technologies, and the presence of leading market players.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-12807

Covid-19 Impact on Mammalian Transient Protein Expression Market

The Impact of the covid-19 pandemic on the mammalian transient protein expression market has largely been negative. Strict lockdown and social distancing regulations has resulted in delayed projects in research and biomedicine applications.

Also, market players have witnessed lower sales and revenue during the crisis period arising from supply chain disruptions, and shortage of adequate manpower. On the other hand, potential for applications in vaccine development is likely to provide opportunities for short-term growth, moderately mitigating loss during this period.

Who is Winning?

In its latest report, Future Market Insights has provided details on key business strategies that are gaining importance in the mammalian transient protein expression market. Market leaders in the industry have been pushing on the expansion of their portfolios with offerings associated to antibody development and gene coding. Also, strategic collaborations are gaining ground in the sector.

Merck KgaA, Thermo Fisher Scientific, Agilent Technologies Inc., Lonza, Mirus Bio Inc., Takara Bio Inc., Qiagen N.V., and Bio-Rad Laboratories Inc., are some of the key companies operating in the mammalian transient protein expression market.

For critical insights, request for PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-12807

Why Future Market Insights?

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Contact Us: